We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AZN market cap is 211.26B. The company's latest EPS is USD 1.9206 and P/E is 56.16.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.42B | 11.49B | 12.02B | 12.68B | 12.94B |
| Operating Income | 2.7B | 1.7B | 1.23B | 3.1B | 2.72B |
| Net Income | 1.82B | 1.37B | 960M | 2.18B | 1.93B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24.38B | 26.62B | 37.42B | 44.35B | 45.81B |
| Operating Income | 1.59B | 4.08B | -293M | 3.54B | 7.89B |
| Net Income | 1.34B | 3.2B | 112M | 3.29B | 5.96B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 96.54B | 96.09B | 101.12B | 102.29B | 104.34B |
| Total Liabilities | 59.13B | 58.87B | 61.95B | 64.79B | 64.74B |
| Total Equity | 37.42B | 37.22B | 39.17B | 37.5B | 39.6B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.38B | 66.73B | 105.36B | 96.48B | 101.12B |
| Total Liabilities | 46.78B | 51.09B | 66.08B | 59.43B | 61.95B |
| Total Equity | 14.6B | 15.64B | 39.29B | 37.06B | 39.17B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.85B | 7.97B | 10.35B | 2.49B | 5.57B |
| Investing | -1.77B | -2.99B | -4.06B | -2.41B | -5.29B |
| Financing | -3.55B | -6.28B | -6.57B | 2.03B | 806M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.97B | 4.8B | 5.96B | 9.81B | 10.35B |
| Investing | -657M | -285M | -11.06B | -2.96B | -4.06B |
| Financing | -1.77B | -2.2B | 3.65B | -6.82B | -6.57B |
| Market Cap | 211.26B |
| Price to Earnings Ratio | 56.16 |
| Price to Sales Ratio | 7.3 |
| Price to Cash Ratio | 57.27 |
| Price to Book Ratio | 8.54 |
| Dividend Yield | 2.14% |
| Shares Outstanding | 3.1B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (0.01%) |
| Company Name | AstraZeneca PLC |
| Address |
1 francis crick avenue cambridge CB2 0AA |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
